<p>IRVINE, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON, AEON WS), a clinical-stage biopharmaceutical company focused on developing a
<p>NZD/USD accelerates down to as low as 0.6816 so far today, on broad based risk aversion. The break of 0.6858 support should firstly confirmed that corrective rise from 0.6804 has completed wi
Leave a Comment